Related Experiment Video
Updated: Jan 27, 2026

Cultivation Methods of Spirochetes from Borrelia burgdorferi Sensu Lato Complex and Relapsing Fever Borrelia
Published on: November 25, 2022
Louse-borne relapsing fever (Borrelia recurrentis infection)
1Nuffield Department of Clinical Medicine,University of Oxford,Oxford,UK.
Abstract:
Louse-borne relapsing fever (LBRF) is an epidemic disease with a fascinating history from Hippocrates' times, through the 6th century 'Yellow Plague', to epidemics in Ireland, Scotland and England in the 19th century and two large Afro-Middle Eastern pandemics in the 20th century. An endemic focus persists in Ethiopia and adjacent territories in the Horn of Africa. Since 2015, awareness of LBRF in Europe, as a re-emerging disease, has been increased dramatically by the discovery of this infection in dozens of refugees arriving from Africa.The causative spirochaete, Borrelia recurrentis, has a genome so similar to B. duttonii and B. crocidurae (causes of East and West African tick-borne relapsing fever), that they are now regarded as merely ecotypes of a single genomospecies. Transmission is confined to the human body louse Pediculus humanus corporis, and, perhaps, the head louse P. humanus capitis, although the latter has not been proved. Infection is by inoculation of louse coelomic fluid or faeces by scratching. Nosocomial infections are possible from contamination by infected blood. Between blood meals, body lice live in clothing until the host's body temperature rises or falls, when they seek a new abode.The most distinctive feature of LBRF, the relapse phenomenon, is attributable to antigenic variation of borrelial outer-membrane lipoprotein. High fever, rigors, headache, pain and prostration start abruptly, 2-18 days after infection. Petechial rash, epistaxis, jaundice, hepatosplenomegaly and liver dysfunction are common. Severe features include hyperpyrexia, shock, myocarditis causing acute pulmonary oedema, acute respiratory distress syndrome, cerebral or gastrointestinal bleeding, ruptured spleen, hepatic failure, Jarisch-Herxheimer reactions (J-HR) and opportunistic typhoid or other complicating bacterial infections. Pregnant women are at high risk of aborting and perinatal mortality is high.Rapid diagnosis is by microscopy of blood films, but polymerase chain reaction is used increasingly for species diagnosis. Severe falciparum malaria and leptospirosis are urgent differential diagnoses in residents and travellers from appropriate geographical regions.High untreated case-fatality, exceeding 40% in some historic epidemics, can be reduced to less than 5% by antibiotic treatment, but elimination of spirochaetaemia is often accompanied by a severe J-HR.Epidemics are controlled by sterilising clothing to eliminate lice, using pediculicides and by improving personal hygiene.
Insights
Louse-borne relapsing fever (LBRF) is an ancient epidemic disease caused by Borrelia recurrentis, transmitted by body lice. Prompt antibiotic treatment significantly reduces its high fatality rate, though Jarisch-Herxheimer reactions can occur.
Area of Science:
- Medical Entomology
- Infectious Diseases
- Epidemiology
Background:
- Louse-borne relapsing fever (LBRF) has a long history, with endemic foci in the Horn of Africa and recent re-emergence in Europe due to refugee migration.
- Borrelia recurrentis, the causative agent, is closely related to tick-borne relapsing fever spirochaetes, considered ecotypes of a single genomospecies.
- Transmission occurs via the human body louse (Pediculus humanus corporis) through inoculation of infected louse fluids or feces.
Purpose of the Study:
- To provide a comprehensive overview of Louse-borne relapsing fever (LBRF).
- To detail the historical context, transmission, clinical manifestations, diagnosis, and control of LBRF.
- To highlight the re-emergence of LBRF in Europe and its public health implications.
Main Methods:
- Review of historical records and epidemiological data on LBRF outbreaks.
- Analysis of the biological characteristics of Borrelia recurrentis and its vector, Pediculus humanus corporis.
- Description of clinical features, diagnostic methods (microscopy, PCR), and treatment outcomes.
Main Results:
- LBRF is characterized by recurrent febrile episodes due to antigenic variation of Borrelia recurrentis.
- Severe manifestations include shock, myocarditis, ARDS, bleeding, and high mortality without treatment (exceeding 40%).
- Antibiotic therapy reduces case-fatality to below 5%, but Jarisch-Herxheimer reactions are common.
Conclusions:
- LBRF remains a significant public health concern, particularly with its re-emergence in Europe.
- Effective control relies on louse elimination through clothing sterilization, pediculicides, and improved hygiene.
- Rapid diagnosis and prompt antibiotic treatment are crucial for managing LBRF and preventing severe outcomes.
Related Concept Videos
The Born-Haber Cycle
Types of Fever
Here are the different types of fever:
Patterns of Fever
Methods of reducing fever
Pharmacological Methods of Reducing Fever:
Infection
The chain begins with pathogens: bacteria, viruses, fungi, prions, or parasites such as protozoa helminths. These can be present on the skin as transient or resident flora, or they can be acquired from the environment. Identifying and treating the type of infection and...
Stages of Infection

